Patents
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
06/2006
06/13/2006US7060875 Methods for delaying leaf senescence using the ORE7 gene
06/13/2006US7060874 Bioengineering cotton fiber properties
06/13/2006US7060873 Comprises preparing transgenic maize, rice, barley or wheat expressing polypeptides with histone deacetylase activity for increasing transcriptional expression and propagation in plants
06/13/2006US7060872 Method for producing plants having modified canopy size or seedless fruit
06/13/2006US7060871 Use of exogenous β-adrenergic receptor and β-adrenergic receptor kinase gene constructs to enhance myocardial function
06/13/2006US7060870 Transgenic mice over-expressing ABAD and mutant APP in brain as model of Alzheimer's disease and uses thereof
06/13/2006US7060868 Autoimmune disease model animal
06/13/2006US7060816 Detection of fungal pathogens using the polymerase chain reaction
06/13/2006US7060815 Breeding hops with transformation techniques and molecular selection techniques
06/13/2006US7060813 Gene expression of chimera gene; transformation of host cells; isolated polynucleotide
06/13/2006US7060812 Nucleotide sequence coding polypeptide for use in the treatment and diagnosis of nervous system disorders
06/13/2006US7060810 Regulation of human eosinophil serine protease 1-like enzyme
06/13/2006US7060809 Locked nucleic acid units may be used in a wide variety of applications, such as PCR primers, sequencing, synthesis of antisense oligonucleotides, diagnostics and the like
06/13/2006US7060805 Methods for isolating tissue factor inhibitor
06/13/2006US7060804 Method for isolating proteins or protein and nucleic acid associations, or particle and protein complexes, reagent and uses
06/13/2006US7060800 Polypeptides for use in the treatment and diagnosis of crohn's disease
06/13/2006US7060795 Comprises nucleotide sequences coding matrix metalloprotease enzyme inhibitors for use in the treatment of injuries; wound healing agents
06/13/2006US7060793 Circularly permuted fluorescent protein indicators
06/13/2006US7060791 Genetic engineering; bone disorders; anticancer agent
06/13/2006US7060790 Genetic engineering; antitumor agents; therapy for microbiocide infections; antiinflammatory agents; immunology
06/13/2006US7060690 For therapy of cancer
06/13/2006US7060688 A gene therapy for cancers, comprising a cancer suppressing gene; genetic engineering, duplicated gene, cloned gene
06/13/2006US7060687 Live vaccines for allergy treatment
06/13/2006US7060682 direct interaction with the ligand-bound receptor and activation of one or more transcription factors; unaffected by the presence or concentration of second messengers; direct interaction with tyrosine kinase domains; absence of interaction with G-proteins; transcriptional stimulation of target genes
06/13/2006US7060673 Fusion peptide of human parathyroid hormone derived peptide and tat peptide, preparation thereof, and skin slimming cosmetic composition comprising the same
06/13/2006US7060669 in aqueous two-phase systems by fusing hydrophobin or hydrophobin-like protein to a protein of interest, such as an extracellular protein of Trichoderma, selected from the group consisting of cellulases, hemicellulases and proteases.
06/13/2006US7060501 contacting a cell containing a polynucleotide with an organophosphate and detecting whether or not hydrolysis has occured; extraction of the hydrolysis product from the cell is not necessary to detect the hydrolysis; the conditions that do not require destruction of the cell.
06/13/2006US7060500 Single-stranded oligodeoxynucleotide mutational vectors
06/13/2006US7060499 causes recombination reaction between two mutant FRT sequences having an identical sequence to each other but does not cause recombination reaction with a wild-type FRT sequence, in the presence of FLP recombinase
06/13/2006US7060498 Polycationic water soluble copolymer and method for transferring polyanionic macromolecules across biological barriers
06/13/2006US7060497 Adeno-associated viral vector-based methods and compositions for introducing an expression cassette into a cell
06/13/2006US7060495 Polypeptide for use in as anticarcinogenic agent
06/13/2006US7060493 used for assays for the detection of Nod2 and Nod2 polymorphisms associated with Crohn's disease and ulcerative colitis
06/13/2006US7060491 Polynucleotides encoding novel BT toxin receptors from lepidopteran insects
06/13/2006US7060490 having an N-terminal domain, a DNA-binding domain and a ligand-binding domain
06/13/2006US7060485 DNA for encoding D-hydantoin hydrolases, DNA for encoding N-carbamyl-D-amino acid hydrolases, recombinant DNA containing the genes, cells transformed with the recombinant DNA, methods for producing proteins utilizing the transformed cells and methods for producing D-amino acids
06/13/2006US7060483 DNA encoding endo-β-galactosidase
06/13/2006US7060481 Comprises peptide for diagnosing and treating inflammatory, tumor, arthritic and nervous system disorders
06/13/2006US7060480 MRE11 orthologue and uses thereof
06/13/2006US7060477 Protein corresponding to recombinant fungal epoxide hydrolase; use making enantiomerically pure diols and/or epoxides
06/13/2006US7060468 Thermostable glucoamylase
06/13/2006US7060467 Generating genetically engineered polypeptides; obtain library of nucleotide sequences, extend nucleotide sequences, denature, incubate with primers, amplify, insert into vector, express polypeptides
06/13/2006US7060466 Methods of producing hyaluronic acid using a recombinant hyaluronan synthase gene
06/13/2006US7060464 Peptides conferring environmental stress resistance and fusion proteins including said peptides
06/13/2006US7060463 DNA molecules encoding Macaca mulatta androgen receptor
06/13/2006US7060462 Agrobacterium tumefaciens outer membrane protein;
06/13/2006US7060461 Genetic engineering; fusion protein
06/13/2006US7060459 TNF-inducible promoters and methods for using
06/13/2006US7060457 Diagnosing nervous system disorders in humans; obtain sample, screen for the presence of aberrant glutamate receptor, presence of receptor indicates nervous system disorder
06/13/2006US7060454 Method for sorting antifungal molecules acting on the glucanosyltransferase activity
06/13/2006US7060450 identifying compounds that mimic a bioactivity of a hedgehog protein by using the fact that hedgehog-related genes comprise morphogenic signals produced by embryonic patterning centers, and are involved in the formation of ordered spatial arrangements of differentiated tissues in vertebrates
06/13/2006US7060449 Method of preparing GALR2 receptors composition
06/13/2006US7060440 extending nascent oligonucleotides via polymerase and hybridizing
06/13/2006US7060438 Method for analyzing a patient's genetic prediposition to at least one disease and amplification adapted to such a method
06/13/2006US7060436 Detecting the presence of an HIV target sequence
06/13/2006US7060435 screening genomic DNA for the presence or absence of both T-475G and A-147G in the transcriptional regulatory region of CYP3A5; identifying as having a high drug metabolizing phenotype if both variants are present, or having a low metabolizing phenotype if both variants are absent
06/13/2006US7060433 Methods and compositions for screening using diphtheria toxin constructs
06/13/2006US7060427 Anthraquinone and its derivatives
06/13/2006US7060284 Polypeptides and polynucleotides for enhancing immune reactivity to HER-2 protein
06/13/2006US7060282 Equine herpesvirus (EHV) mutants are stable and have reduced virulence, which makes them very suitable for use in a live vaccine; vaccines comprising EHV mutants, DNA sequences and vectors harbouring a mutated EHV sequence, host cells transfected with the DNA
06/13/2006US7060281 Groups of barrelia burgdorferi and borrelia afzelii that cause lyme disease in humans
06/13/2006US7060279 Compositions and methods for dendritic cell-based immunotherapy
06/13/2006US7060278 Bv8 nucleic acids and polypeptides with mitogenic activity
06/13/2006US7060276 Plasmodium falciparum AMA-1 protein and uses thereof
06/13/2006US7060272 Death domain containing receptor-4 agonist antibodies and methods
06/13/2006US7060269 Anti-VEGF antibodies
06/13/2006US7060267 MASP-2, a complement-fixing enzyme, and uses for it
06/13/2006US7060266 Human brain carboxypeptidase B
06/13/2006US7060265 Cloning and recombinant production of polistinae venom enzymes, such as phospholipase and hyaluronidase, and immunological therapies based thereon
06/13/2006US7060264 use of patatin and structurally related proteins which have insect inhibitory properties; Coleoptera; monocotyledons;
06/13/2006US7060261 Nucleotide sequences coding polypeptide for us ein the treatment of immunological disorders
06/13/2006US7060224 Methods for the electronic, homogeneous assembly and fabrication of devices
06/13/2006US7060173 Using Gradiflow electrophoresis technology for macromolecule separation which utilises tangential flow across the membrane
06/13/2006CA2155434C Prohormone convertase transformed cells and polypeptide synthesis
06/13/2006CA2133338C Heterologous gene expression in bacillus subtilis: fusion approach
06/13/2006CA2064761C Methods and compositions for the production of stably transformed fertile monocot plants and cells thereof
06/11/2006CA2526686A1 Expression cassettes for regulating meristem-preferential or meristem-specific expression in plants
06/08/2006WO2006060823A2 Apoptosis-specific eif-5a and polynucleotides encoding same
06/08/2006WO2006060598A2 RNA INTERFERENCE MEDIATED INHIBITION OF INTERLEUKIN AND INTERLEUKIN RECEPTOR GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
06/08/2006WO2006060484A2 Tuberculosis nucleic acids, polypeptides and immunogenic compositions
06/08/2006WO2006060454A2 Methods of designing small interfering rnas, antisense polynucleotides, and other hybridizing polynucleotides
06/08/2006WO2006060314A2 Generation of replication competent viruses for therapeutic use
06/08/2006WO2006060257A2 Bacterial packaging strains usefuel for generation and production of recombinant double-stranded rna nucleocapsids and uses thereof
06/08/2006WO2006060182A2 HIGHLY BRANCHED HK PEPTIDES AS EFFECTIVE CARRIERS OF siRNA
06/08/2006WO2006060062A2 Trichoderma reesei glucoamylase and homologs thereof
06/08/2006WO2006060020A1 Sm5-1 antibodies and applications thereof
06/08/2006WO2006059769A1 Method of diagnosing malignant lymphoma and estimating the prognosis thereof
06/08/2006WO2006059717A1 Method of analyte organism identification, internal standard dna composition for use in this method and process for producing the same
06/08/2006WO2006059715A1 Process for producing l-lysine and l-arginine using methanol assimilating bacterium
06/08/2006WO2006059712A1 Monoclonal antibody binding to human steroid sulfatase
06/08/2006WO2006059709A1 Novel gst tag sequence and utilization of the same
06/08/2006WO2006059691A1 Method of screening antiobesity drug
06/08/2006WO2006059655A1 Method of separating microorganism or cells
06/08/2006WO2006059638A1 Anti-hiv drug, polypeptide constituting the same, gene encoding the polypeptide and method of producing the anti-hiv drug
06/08/2006WO2006059593A1 Biological substance separating device using electrolytic cutting affinity carrier
06/08/2006WO2006059529A1 Hla-a24-restricted tumor antigen peptide
06/08/2006WO2006059507A1 11β-HSD1 ANTISENSE COMPOUND
06/08/2006WO2006059433A1 Novel anthocyanidin glucosyltransferase gene
06/08/2006WO2006059386A1 Method of isolating double-stranded dna containing simple sequence repeats
06/08/2006WO2006059323A2 Production of proteins